Logo

Foundation Medicine

Foundation Medicine, Science 37 Partner to Develop Home-Based Clinical Trial Model

Foundation will identify patients that may be eligible for clinical trials, and Science 37 will enroll them and provide ongoing support.

Foundation Medicine, Epic Ink Deal to Integrate Genomic Tests Into EMR Network

The integration is intended to support oncology practices, academic medical centers, and other health systems by providing access to clinical and genomic info.

People in the News: New Appointments at Guardant Health, Foundation Medicine, PGDx, GenapSys, More

FDA Approves Foundation Medicine's Liquid Biopsy Test as CDx for Novartis' Tabrecta in NSCLC

The blood-based test is the second Foundation Medicine assay approved to ID patients eligible for the drug due to mutations leading to MET exon 14 skipping.

FDA Approves FoundationOne CDx for Takeda's ALK-Inhibitor

The agency approved Foundation Medicine's tissue-based, next-generation sequencing test to identify patients with ALK-positive NSCLC eligible for Alunbrig.

May 21, 2021

Guardant Health to License IP to Foundation Medicine for $25M, Royalties Under Settlement Agreement

Mar 9, 2021

Foundation Medicine, InformedDNA Partner to Expand Genetic Counseling for Cancer Patients

Jan 22, 2021

People in the News: New Appointments at Foundation Medicine, Sophia Genetics, Circulogene; More

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Nov 18, 2020

Foundation Medicine Licenses Mutation Detection Technology From TwinStrand Biosciences

Nov 17, 2020

Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition

Nov 9, 2020

FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Lynparza

Nov 2, 2020

Regulatory Documents for Newly Approved Liquid Biopsy NGS Panels Detail Diverse Test Claims, Methods
Premium

Oct 27, 2020

FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Three Targeted Therapies

Oct 26, 2020

FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients

Sep 18, 2020

Foundation Medicine, Takeda Collaborate to Develop CDx for NSCLC Therapies

Sep 16, 2020

Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable
Premium

Aug 28, 2020

Stakeholders Scramble to Predict Impact of HHS Move Limiting FDA Ability to Regulate LDTs
Premium

Aug 27, 2020

Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Diagnostic Indications

Aug 17, 2020

Foundation Medicine, OneOncology Partner to Bring Precision Oncology to Community Practices

Aug 5, 2020

TargetCancer Foundation Initiates Precision Medicine Study for Rare Cancers

Jul 24, 2020

TMB Harmonization Effort Yields Calibration Method to Correct Inter-Assay Variation
Premium

Jul 10, 2020

Presence of cfDNA, CTCs Predicts Recurrence in Triple-Negative Breast Cancer

Jun 30, 2020

Foundation Medicine Shifts Focus to Early Cancer Detection With Lexent Bio Acquisition
Premium

Jun 19, 2020

People in the News: Geoffrey Oxnard, Christopher O'Connell, Thierry Bernard, More

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.